mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
DBeQ |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
phloretin |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
KH-CB19 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.005 |
mRNA |
PRIMA-1-Met |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.005 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.32 |
0.005 |